Literature DB >> 26180119

Neurotensin inhibits both dopamine- and GABA-mediated inhibition of ventral tegmental area dopamine neurons.

Katherine Stuhrman1, Aaron G Roseberry2.   

Abstract

Dopamine is an essential neurotransmitter that plays an important role in a number of different physiological processes and disorders. There is substantial evidence that the neuropeptide neurotensin interacts with the mesolimbic dopamine system and can regulate dopamine neuron activity. In these studies we have used whole cell patch-clamp electrophysiology in brain slices from mice to examine how neurotensin regulates dopamine neuron activity by examining the effect of neurotensin on the inhibitory postsynaptic current generated by somatodendritic dopamine release (D2R IPSC) in ventral tegmental area (VTA) dopamine neurons. Neurotensin inhibited the D2R IPSC and activated an inward current in VTA dopamine neurons that appeared to be at least partially mediated by activation of a transient receptor potential C-type channel. Neither the inward current nor the inhibition of the D2R IPSC was affected by blocking PKC or calcium release from intracellular stores, and the inhibition of the D2R IPSC was greater with neurotensin compared with activation of other Gq-coupled receptors. Interestingly, the effects of neurotensin were not specific to D2R signaling as neurotensin also inhibited GABAB inhibitory postsynaptic currents in VTA dopamine neurons. Finally, the effects of neurotensin were significantly larger when intracellular Ca(2+) was strongly buffered, suggesting that reduced intracellular calcium facilitates these effects. Overall these results suggest that neurotensin may inhibit the D2R and GABAB IPSCs downstream of receptor activation, potentially through regulation of G protein-coupled inwardly rectifying potassium channels. These studies provide an important advance in our understanding of dopamine neuron activity and how it is controlled by neurotensin.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  D2R; GABAB; GIRK; TrpC; calcium; dopamine; neurotensin

Mesh:

Substances:

Year:  2015        PMID: 26180119      PMCID: PMC4571768          DOI: 10.1152/jn.00279.2015

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  59 in total

1.  Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody.

Authors:  A Fassio; G Evans; R Grisshammer; J P Bolam; M Mimmack; P C Emson
Journal:  Neuropharmacology       Date:  2000-06-08       Impact factor: 5.250

2.  Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization.

Authors:  I Lépée-Lorgeoux; C Betancur; W Rostène; D Pélaprat
Journal:  Brain Res Dev Brain Res       Date:  1999-03-12

3.  Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons.

Authors:  Michael J Beckstead; David K Grandy; Kevin Wickman; John T Williams
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

4.  Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals.

Authors:  A Björklund; O Lindvall
Journal:  Brain Res       Date:  1975-01-17       Impact factor: 3.252

Review 5.  Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms.

Authors:  H Morikawa; C A Paladini
Journal:  Neuroscience       Date:  2011-08-16       Impact factor: 3.590

Review 6.  Neurotensin and neurotensin receptors.

Authors:  J P Vincent; J Mazella; P Kitabgi
Journal:  Trends Pharmacol Sci       Date:  1999-07       Impact factor: 14.819

7.  Activation of D₂-like receptors in rat ventral tegmental area inhibits cocaine-reinstated drug-seeking behavior.

Authors:  Yueqiang Xue; Jeffery D Steketee; George V Rebec; Wenlin Sun
Journal:  Eur J Neurosci       Date:  2011-01-24       Impact factor: 3.386

Review 8.  Reward mechanisms in obesity: new insights and future directions.

Authors:  Paul J Kenny
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

9.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs.

Authors:  S W Johnson; R A North
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

10.  Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies.

Authors:  G K Aghajanian; B S Bunney
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

View more
  11 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

2.  Diverse actions of the modulatory peptide neurotensin on central synaptic transmission.

Authors:  Christopher W Tschumi; Michael J Beckstead
Journal:  Eur J Neurosci       Date:  2018-02-28       Impact factor: 3.386

3.  Neurotensin speeds inhibition of dopamine neurons through temporal modulation of GABAA and GABAB receptor-mediated synaptic input.

Authors:  Christopher W Tschumi; Michael J Beckstead
Journal:  Neuropharmacology       Date:  2018-01-05       Impact factor: 5.250

Review 4.  Role of central neurotensin in regulating feeding: Implications for the development and treatment of body weight disorders.

Authors:  Laura E Schroeder; Gina M Leinninger
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-27       Impact factor: 5.187

5.  Neuropeptide-Y alters VTA dopamine neuron activity through both pre- and postsynaptic mechanisms.

Authors:  Katherine Stuhrman West; Aaron G Roseberry
Journal:  J Neurophysiol       Date:  2017-05-03       Impact factor: 2.714

6.  Neurotensin Release from Dopamine Neurons Drives Long-Term Depression of Substantia Nigra Dopamine Signaling.

Authors:  Christopher W Tschumi; Harris E Blankenship; Ramaswamy Sharma; William B Lynch; Michael J Beckstead
Journal:  J Neurosci       Date:  2022-07-06       Impact factor: 6.709

7.  Alpha-melanocyte stimulating hormone increases the activity of melanocortin-3 receptor-expressing neurons in the ventral tegmental area.

Authors:  Katherine Stuhrman West; Chunxia Lu; David P Olson; Aaron G Roseberry
Journal:  J Physiol       Date:  2019-05-26       Impact factor: 5.182

8.  Activity-dependent somatodendritic dopamine release in the substantia nigra autoinhibits the releasing neuron.

Authors:  Takuya Hikima; Christian R Lee; Paul Witkovsky; Julia Chesler; Konstantin Ichtchenko; Margaret E Rice
Journal:  Cell Rep       Date:  2021-04-06       Impact factor: 9.423

9.  Antagonism of Neurotensin Receptors in the Ventral Tegmental Area Decreases Methamphetamine Self-Administration and Methamphetamine Seeking in Mice.

Authors:  Sergio Dominguez-Lopez; Elisabeth Piccart; William B Lynch; Mackenna B Wollet; Amanda L Sharpe; Michael J Beckstead
Journal:  Int J Neuropsychopharmacol       Date:  2018-04-01       Impact factor: 5.176

10.  Neurotensin receptor 1 deletion decreases methamphetamine self-administration and the associated reduction in dopamine cell firing.

Authors:  Sergio Dominguez-Lopez; Ramaswamy Sharma; Michael J Beckstead
Journal:  Addict Biol       Date:  2019-11-19       Impact factor: 4.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.